Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2009
06/10/2009CN100496525C Technique of extracting acitve ingredient from roots, stems and leaves from artichoke and application
06/10/2009CN100496512C Pearl suspension
06/10/2009CN100496509C Carbon monoxide product and its uses for treating ileus
06/10/2009CN100496298C Process for producing liquid formulation containing raw yeast and liquid formulation
06/09/2009US7544853 C1 inhibitor with short half-life transient treatment
06/09/2009US7544835 Carboxylic acid derivative and salt thereof
06/09/2009US7544788 Isolated nucleic acid molecule encoding a neurotrophic growth factor
06/09/2009US7544710 Strontium ranelate for use in the treatment of gastro-duodenal pain and especially gastritis and duodenitis and any inflammation of the mucosa of the stomach whether acute or chronic
06/09/2009US7544709 Derivatives of andrimide and moiramide B having antibacterial properties
06/09/2009US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide
06/09/2009US7544700 4-chloro-N-((5-((4-(hexylamino)piperidin-1-yl)sulfonyl)thien-2 -yl)methyl)benzamide for example; JUN kinase inhibitors to treat nervous system disorders, cancer, cardiovascular and autoimmune disorders
06/09/2009US7544692 Dissolved in water; recrystallized, dehydrated; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus, hepatitis virus
06/09/2009US7544684 Hydrazono-malonitriles
06/09/2009US7544669 Polynucleotide therapy
06/09/2009CA2444814C Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
06/09/2009CA2441007C Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
06/09/2009CA2410706C Composition and applicator for topical substance delivery
06/09/2009CA2403721C Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor
06/09/2009CA2403345C System for the controlled delivery of an active material to a dental site
06/09/2009CA2162900C New peptide derivatives
06/04/2009WO2009070533A1 Methods of inhibiting steroyl coa desaturase
06/04/2009WO2009070378A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition
06/04/2009WO2009070116A1 A quinoline derivative acting as a p2x7-receptor antagonist
06/04/2009WO2009069736A1 Nitrogenated compound
06/04/2009WO2009069682A1 Therapeutic agent or preventive agent for hepatitis
06/04/2009WO2009069680A1 Medicinal composition for treating gastrointestinal stromal tumor (gist) and kit and method for estimating the prognosis of patient suffering from gastrointestinal stromal tumor
06/04/2009WO2009069546A1 Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome
06/04/2009WO2009069280A1 Method for producing granulated matter
06/04/2009WO2009069131A1 Alginate biomaterials for the treatment of hepatic disorders
06/04/2009WO2009068989A1 Benzomorphan compounds
06/04/2009WO2009068600A1 Compositions for reducing dental erosion
06/04/2009WO2009068552A1 Piperazinyl-sulfonamide derivatives useful in the treatment of gpr38 receptor mediated diseases
06/04/2009WO2009048289A3 Pharmaceutical composition for treating hepatitis c virus infection comprising hmg-coa reductase inhibitor and bile acid
06/04/2009WO2009027753A4 Composition and method inhibiting inflammation
06/04/2009WO2009022346A3 Phenyl carbamates for treating gastrointestinal inflammation
06/04/2009WO2008013630A3 Calcium aluminosilicate pharmaceutical
06/04/2009US20090143571 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance
06/04/2009US20090143469 Salts of nateglinide
06/04/2009US20090143462 Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
06/04/2009US20090143455 Pyrazoles Useful in the Treatment of Inflammation
06/04/2009US20090143438 Novel Pyridine Derivative Having Anti-Helicobacter Pylori Activity
06/04/2009US20090143426 Synthesis of 1,3,6-trisubstituted-2-carboxyquinol-4-ones as selective ET A antagonists and their use as medicaments
06/04/2009US20090143424 Tetrakis-quaternary ammonium salts and methods for modulating neuronal nicotinic acteylcholine receptors
06/04/2009US20090143406 New Phenylpiperazine
06/04/2009US20090143402 Isoquinolinone derivatives as nk3 antagonists
06/04/2009US20090143386 Human adam-10 inhibitors
06/04/2009US20090143372 Chemical compounds
06/04/2009US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors
06/04/2009US20090143343 Compositions for the treatment of inflammation of the gastrointestinal tract
06/04/2009US20090143332 Cyclodextrin Cyanohydrins
06/04/2009US20090143319 Transcription factor decoy
06/04/2009US20090143310 Method of stimulating the motility of the gastrointestinal system using ipamorelin
06/04/2009US20090143309 converting an agonist of protein kinase C to an antagonist of protein kinase C; amino acid sequences; crosslinked via an N-terminal Cys-Cys bond to a peptide to facilitate transport cellular uptake
06/04/2009US20090142782 Using actinobacillus specific immunogolbulins to diagnose gum disease
06/04/2009US20090142394 Gastric Antacid
06/04/2009US20090142375 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses madiated by gram-negative bacteria, potential pathogenic gram-positive bacteria
06/04/2009US20090142326 Glycosidase Enzymes
06/04/2009US20090142315 Methods for the Dietary Management of Irritable Bowel Syndrome and Carbohydrate Malabsorption
06/04/2009US20090142295 Anti-Connexin Compounds and Uses Thereof
06/04/2009CA2707174A1 Benzomorphan compounds
06/04/2009CA2706973A1 Alginate biomaterials for the treatment of hepatic disorders
06/04/2009CA2706800A1 Novel use
06/04/2009CA2706768A1 Methods of treating non-alcoholic steatohepatitis (nash) using cysteamine products
06/04/2009CA2706656A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition
06/04/2009CA2706429A1 Compositions for treating an intestinal inflammatory condition
06/04/2009CA2704826A1 Method for producing granulated preparation
06/03/2009EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
06/03/2009EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
06/03/2009EP2065379A1 Benzimidazole compound having gastric acid secretion inhibitory activity
06/03/2009EP2065375A1 A process for the preparation of 7-carboxymethyloxy-3',4', 5-trimethoxy flavone
06/03/2009EP2065052A2 Anti-IgE vaccines
06/03/2009EP2065051A2 Composition for maintaining gastrointestinal homeostasis comprising albumin and tannic acid
06/03/2009EP2065046A1 Gip secretion inhibitor
06/03/2009EP2063962A2 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder
06/03/2009EP2063905A2 Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
06/03/2009EP1940247B1 Method for stimulating intestinal barrier integrity after non-natural birth
06/03/2009EP1399440B1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors
06/03/2009EP1263720B1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
06/03/2009EP1218544B1 TAR RNA binding peptides
06/03/2009EP1140079B1 Assays for ligands for nuclear receptors
06/03/2009EP0928184B1 Anti-caries oral compositions
06/03/2009CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
06/03/2009CN101445504A Dioxane-2-alkyl carbamates derivatives
06/03/2009CN101445463A Beta2-adrenergic receptor agonists
06/03/2009CN101444511A Low dose entecavir formulation and use
06/03/2009CN101444509A Triple monoamine reuptake inhibitors for the treatment of chronic pain
06/03/2009CN101444496A Compounds for the treatment of metabolic disorders
06/03/2009CN100494398C Method of determining glutachione-S-transferase pi expression
06/03/2009CN100494388C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
06/03/2009CN100494380C A nucleodite sequence of anti-hepatitis virus C infection and preventing and curing hepatitis virus C and its fragment and application
06/03/2009CN100494190C Compound containing o-naphthaquinone and application
06/03/2009CN100494185C Novel quaternary ammonium compounds
06/03/2009CN100494182C Regulatory factor of tumor necrosis alpha factor
06/03/2009CN100493545C Process for preparing kidney-tonifying wolfberry fruit capsule
06/03/2009CN100493501C Scopolamine hydrobromide dry powder inhalant for nose and preparing method
06/03/2009CN100493495C Novel schisandra fruit soft capsule formulation and its preparation method
06/03/2009CN100493494C American ginseng oral disintegration tablet and its preparing process
06/02/2009US7541477 hormone inhibitor 5-(4-fluorophenyl)-N-{2-[isopropyl(methyl)amino]-1H-benzimidazol-6-yl}-2-pyridinecarboxamide; treating the disorders of cardiovascular system, nervous system, metabolic systems, reproductive system, respiratory system, digestive system
06/02/2009US7541375 Azole derivatives and pharmaceutical compositions containing them
06/02/2009US7541369 Amino-derivatives as novel inhibitors of histone deacetylase
1 ... 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 ... 1258